Alkermes
ALKS
#2518
Rank
S$9.20 B
Marketcap
S$55.21
Share price
-1.34%
Change (1 day)
35.14%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): S$0.30 Billion

According to Alkermes's latest financial reports the company's current earnings are S$1.56 Billion. In 2025 the company made an earning of S$0.39 Billion a decrease over its 2024 earnings that were of S$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.30 B-22.46%
2025 S$0.39 B-34.87%
2024 S$0.60 B-17.97%
2023 S$0.73 B-468.52%
2022 -S$0.2 Billion449.24%
2021 -S$36.23 Million-68.04%
2020 -S$0.12 Billion-52.1%
2019 -S$0.24 Billion64.49%
2018 -S$0.15 Billion-15.04%
2017 -S$0.17 Billion-34.2%
2016 -S$0.26 Billion-5.34%
2015 -S$0.28 Billion35084.97%
2014 -S$0.78 Million
2012 S$9.57 M-117.81%
2011 -S$53.77 Million-12.69%
2010 -S$61.58 Million94.3%
2009 -S$31.7 Million-117.7%
2008 S$0.17 B622.63%
2007 S$24.77 M
2004 -S$98 Million-14.48%
2003 -S$0.12 Billion11.88%
2002 -S$0.11 Billion39.65%
2001 -S$73.35 Million5.73%
2000 -S$69.37 Million-28.91%
1999 -S$97.58 Million237.28%
1998 -S$28.93 Million100.05%
1997 -S$14.47 Million-37.93%
1996 -S$23.3 Million82.72%
1995 -S$12.75 Million-26.79%
1994 -S$17.42 Million-72.78%
1993 -S$63.98 Million208.07%
1992 -S$20.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.51 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.35 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.66 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.87 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$12.37 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.91 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-S$0.28 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.36 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.92 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel